Company intelligence / Profile preview
Griffen
Amsterdam, North Holland, Netherlandsgriffindiscoveries.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Griffin Discoveries is a biotechnology company focused on the discovery and development of small molecule drugs targeting G protein-coupled receptors (GPCRs). The company leverages its proprietary drug discovery platform to identify novel ligands for challenging targets, with a primary focus on histamine and chemokine receptors. Their research programs aim to address significant unmet needs in inflammatory disorders, allergic conditions, and oncology. By utilizing advanced molecular pharmacology and medicinal chemistry, Griffin Discoveries develops high-affinity compounds designed for improved therapeutic efficacy and safety profiles.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Griffen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Griffen.